Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn B Beaulieu

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
World Journal of Gastroenterology|July 8, 2011
Inflammatory bowel disease in pregnancyDawn B Beaulieu, Sunanda Kane
Gastroenterology Clinics of North America|May 24, 2011
Inflammatory bowel disease in pregnancyDawn B Beaulieu, Sunanda Kane
The American Journal of Gastroenterology|March 6, 2026
Long-term Infant Outcomes After In Utero Biologic Exposure: Results from the Pregnancy Inflammatory Disease Neonatal Outcomes (PIANO) RegistryArushi Kohli, Millie D Long, Dawn B Beaulieu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 6, 2017
Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to VaccinesDawn B Beaulieu, Ashwin N Ananthakrishnan, Christopher Martin, et al.
Inflammatory Bowel Diseases|May 21, 2015
Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional TreatmentsScott A Merkley, Dawn B Beaulieu, Sara Horst, et al.
The American Journal of Gastroenterology|October 5, 2023
Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO RegistryRishika Chugh, Millie D Long, Yue Jiang, et al.
Digestive Diseases and Sciences|October 21, 2017
Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel DiseaseAlexis Calloway, Robin Dalal, Dawn B Beaulieu, et al.
Inflammatory Bowel Diseases|April 15, 2017
Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for SurgeryDawn W Adams, Shelly Gurwara, Heidi J Silver, et al.
Biomedical Optics Express|March 9, 2017
Clinical characterization of <i>in vivo</i> inflammatory bowel disease with Raman spectroscopyIsaac J Pence, Dawn B Beaulieu, Sara N Horst, et al.
Crohn'S & Colitis 360|August 4, 2020
Gastroenterologist-Lead Management of Iron Deficiency Anemia in Inflammatory Bowel Disease Is Effective, Safe, and May Increase Quality of LifeChristopher L Coe, Matthew H Meyers, Dawn B Beaulieu, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
World Journal of Gastroenterology|July 8, 2011
Inflammatory bowel disease in pregnancyDawn B Beaulieu, Sunanda Kane
Gastroenterology Clinics of North America|May 24, 2011
Inflammatory bowel disease in pregnancyDawn B Beaulieu, Sunanda Kane
The American Journal of Gastroenterology|March 6, 2026
Long-term Infant Outcomes After In Utero Biologic Exposure: Results from the Pregnancy Inflammatory Disease Neonatal Outcomes (PIANO) RegistryArushi Kohli, Millie D Long, Dawn B Beaulieu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 6, 2017
Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to VaccinesDawn B Beaulieu, Ashwin N Ananthakrishnan, Christopher Martin, et al.
Inflammatory Bowel Diseases|May 21, 2015
Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional TreatmentsScott A Merkley, Dawn B Beaulieu, Sara Horst, et al.
The American Journal of Gastroenterology|October 5, 2023
Maternal and Neonatal Outcomes in Vedolizumab- and Ustekinumab-Exposed Pregnancies: Results From the PIANO RegistryRishika Chugh, Millie D Long, Yue Jiang, et al.
Digestive Diseases and Sciences|October 21, 2017
Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel DiseaseAlexis Calloway, Robin Dalal, Dawn B Beaulieu, et al.
Inflammatory Bowel Diseases|April 15, 2017
Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for SurgeryDawn W Adams, Shelly Gurwara, Heidi J Silver, et al.
Biomedical Optics Express|March 9, 2017
Clinical characterization of <i>in vivo</i> inflammatory bowel disease with Raman spectroscopyIsaac J Pence, Dawn B Beaulieu, Sara N Horst, et al.
Crohn'S & Colitis 360|August 4, 2020
Gastroenterologist-Lead Management of Iron Deficiency Anemia in Inflammatory Bowel Disease Is Effective, Safe, and May Increase Quality of LifeChristopher L Coe, Matthew H Meyers, Dawn B Beaulieu, et al.
Pageof 5